Apply to trial NCT07141329

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 2Drug trial

SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures

This is a Phase 2b open-label extension study to evaluate the long-term safety and efficacy of SPN-817.

How this works

  1. Answer a few questions

    About 5 to 10 minutes. Skip-friendly where possible.

  2. We connect you with the study team

    When a site picks up your application, we introduce you to their team directly — with you on the thread.

  3. The team reaches out to schedule screening

    Usually within a few business days, via the contact you give.

We save your progress under this email and copy you when we connect you with the study team.

By continuing, you agree to our terms of service.